Prevention

As health officials continue to recommend the injectable influenza vaccine to prevent illness this season, a new study examines whether vaccination rates changed after the CDC stopped recommending the nasal spray vaccine

According to recent data from the Centers for Disease Control and Prevention, millions of Americans aged 13-17 are under-vaccinated against serious infectious diseases.

A new CDC report finds that although vaccination coverage is high for kindergarteners in the United States, pockets of undervaccination are a cause for concern among health officials.

The FDA has approved Shingrix, GlaxoSmithKline’s recombinant zoster vaccine against shingles, for patients 50 and older.

At ID Week 2017, Dr. Laura Cooley, CDC, discussed the increasing number of Legionnaires’ cases in the United States, underscoring the need for stronger water management practices.

Researchers turn to the literature to assess if the antibiotic cefepime causes neurotoxicity.

Although there have been important improvements to existing vaccines, the list of vaccine-preventable diseases has barely changed at all in over two decades.

Silvia Munoz-Price, MD, PhD, calls for more microbiome research in order to ultimately improve patient care in hospitals.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

James S. Lewis, PharmD, FIDSA, shares different proposals shared in the health care community to incentivize pharmaceutical companies to develop needed drugs.

Infection prevention goes beyond healthcare workers. Here's why we should all celebrate this week.

A recent study has found that 1 in 9 men living in the United States have oral HPV.

Brinda Emu, MD, offers insight into the HIV monoclonal antibody ibalizumab.

A new article details how researchers are working to develop a universal flu shot.

The pneumonic plague outbreak in Madagascar infects 684 individuals and claims 57 lives, thus far. Has it spread to Seychelles?

New research supports that allergy evaluation is an inexpensive intervention and that given the downstream benefits, it may well be cost-effective.

NIAID director Dr. Anthony S. Fauci stresses in a recent commentary that, from a practical standpoint, the development of a moderately effective HIV vaccine is “essential” to ending the pandemic.

Monica Mahoney, PharmD, BCPS-AQ ID, explains the first-line empiric therapy for candidemia.

Researchers in a pediatric hospital in Tokyo see positive results following the implementation of an antibiotic stewardship program limiting carbapenem use.

Ciara Kennedy, PhD, breaks down APX001, a new antifungal with a unique mechanism of action.

The declaration was made to help direct funds towards controlling the outbreak and providing adult hepatitis A vaccines to those in need.

Magda Opsomer, MD, reveals who will benefit from the darunavir single-tablet HIV regimen.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Dr. Daniel Lucey provided insight on past and current yellow fever outbreaks and vaccine shortages at ID Week 2017; he also cited the very real possibility of yellow fever hitting Asia.

Researchers from the University of Colorado Boulder have developed nanoparticles capable of boosting the effectiveness of antibiotics against drug-resistant superbugs.

IDSA and HIVMA urge Congress to approve emergency funding for hurricane response efforts in Puerto Rico and the US Virgin Islands and to prevent future public health crises.

Evelyn J. Ellis-Grosse, PhD, chief scientific officer of Zavante Therapeutics, explains why Zavante Therapeutic’s fosfomycin is a unique, novel antimicrobial.

Presenters combed through the barrage of clinical trials to share those that could be practice-changing for clinicians.

Flu season has officially begun in the United States, as the first cases and deaths of the season are reported, prompting health officials to press for vaccination.

A new study pulls back the curtain into a complex web of resistance, colonization, and the challenges of antimicrobial resistance in this setting.